HCPCS Code J7681

Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Code effective Jan 01, 2007

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J7681 is a valid 2026 HCPCS code meaning Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram or (Terbutaline sulf comp unit) for short. HCPCS J7681 has been effective since 01/01/2007 and applies to Medical care.


HCPCS Code Details - J7681

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7681
Description

Long description:
Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram

Short description:
Terbutaline sulf comp unit

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code D - Special coverage instructions apply
BETOS2 code D1G - Drugs Administered through DME
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2007
Date added Added Jan 01, 2000

See also

  • HCPCS J7680 · Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

  • HCPCS J7682 · Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/13/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.